{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:30:00Z","timestamp":1791063000899,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s10620-009-0797-1","type":"journal-article","created":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T20:02:44Z","timestamp":1240862564000},"page":"579-585","source":"Crossref","is-referenced-by-count":44,"title":["Pneumonitis as A Consequence of (Peg)Interferon-Ribavirin Combination Therapy for Hepatitis\u00a0C: a Review of the Literature"],"prefix":"10.1007","volume":"55","author":[{"given":"Serena","family":"Slavenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne F.","family":"Heijdra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P. H.","family":"Drenth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"797_CR1","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","volume":"355","author":"JH Hoofnagle","year":"2006","unstructured":"Hoofnagle JH, Seeff L. Peginterferon and ribavirin for chronic hepatitis\u00a0C. N Engl J Med. 2006;355:2444\u20132451. doi: 10.1056\/NEJMct061675 .","journal-title":"N Engl J Med"},{"key":"797_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"GM Lauer","year":"2001","unstructured":"Lauer GM, Walker BD. Hepatitis\u00a0C virus infection. N Engl J Med. 2001;345:41\u201352. doi: 10.1056\/NEJM200107053450107 .","journal-title":"N Engl J Med"},{"key":"797_CR3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/0140-6736(90)93356-T","volume":"336","author":"HL Janssen","year":"1990","unstructured":"Janssen HL, Berk L, Vermeulen M, Schalm SW. Seizures associated with low-dose alpha-interferon. Lancet. 1990;336:1580. doi: 10.1016\/0140-6736(90)93356-T .","journal-title":"Lancet"},{"key":"797_CR4","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","volume":"36","author":"MW Fried","year":"2002","unstructured":"Fried MW. Side effects of therapy of hepatitis\u00a0C and their management. Hepatology. 2002;36:S237\u2013S244. doi: 10.1002\/hep.1840360730 .","journal-title":"Hepatology"},{"key":"797_CR5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","volume":"24","author":"G Fattovich","year":"1996","unstructured":"Fattovich G, Giustina G, Favarato S. Ruol A. A survey of adverse events in 11, 241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol. 1996;24:38\u201347. doi: 10.1016\/S0168-8278(96)80184-X .","journal-title":"J Hepatol"},{"key":"797_CR6","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/j.1572-0241.2002.05999.x","volume":"97","author":"K ShivaKumar","year":"2002","unstructured":"ShivaKumar K, Russo MW, Borczuk AC, et\u00a0al. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis\u00a0C. Am J Gastroenterol. 2002;97:2432\u20132440. doi: 10.1111\/j.1572-0241.2002.05999.x .","journal-title":"Am J Gastroenterol"},{"key":"797_CR7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1086\/425746","volume":"39","author":"J Midturi","year":"2004","unstructured":"Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J. Spectrum of pulmonary Toxicity associated with use of interferon therapy for hepatitis\u00a0C. Case report and review of literature. Clin Infect Dis. 2004;39:1724\u20131729. doi: 10.1086\/425746 .","journal-title":"Clin Infect Dis"},{"key":"797_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","volume":"25","author":"T Okanoue","year":"1996","unstructured":"Okanoue T, Sakamoto S, Itoh Y, et\u00a0al. Side effects of high-dose interferon therapy for chronic hepatitis\u00a0C. J Hepatol. 1996;25:283\u2013291. doi: 10.1016\/S0168-8278(96)80113-9 .","journal-title":"J Hepatol"},{"key":"797_CR9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bmj.306.6882.896-c","volume":"306","author":"T Kamisako","year":"1993","unstructured":"Kamisako T, Adachi Y, Chihara J, Yamamoto T. Interstitial pneumonitis and interferon-alfa. BMJ. 1993;306:896.","journal-title":"BMJ"},{"key":"797_CR10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1378\/chest.105.3.939","volume":"105","author":"K Chin","year":"1994","unstructured":"Chin K, Tabata C, Sataka N, Nagai S, Moriyasu F, Kuno K. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis\u00a0C. Chest. 1994;105:939\u2013941. doi: 10.1378\/chest.105.3.939 .","journal-title":"Chest"},{"key":"797_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2169\/internalmedicine.33.337","volume":"33","author":"N Hizawa","year":"1994","unstructured":"Hizawa N, Kojima J, Kojima T, et\u00a0al. A patient with chronic hepatitis\u00a0C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration. Intern Med. 1994;33:337\u2013341. doi: 10.2169\/internalmedicine.33.337 .","journal-title":"Intern Med"},{"key":"797_CR12","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1183\/09031936.96.09122691","volume":"9","author":"T Ishizaki","year":"1996","unstructured":"Ishizaki T, Sasaki F, Ameshima S, et\u00a0al. Pneumonitis during interferon and\/or herbal drug therapy in patients with chronic active hepatitis. Eur Respir J. 1996;9:2691\u20132696. doi: 10.1183\/09031936.96.09122691 .","journal-title":"Eur Respir J"},{"key":"797_CR13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF02361253","volume":"29","author":"K Moriya","year":"1994","unstructured":"Moriya K, Yasuda K, Koike K, et\u00a0al. Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis\u00a0C. J Gastroenterol. 1994;29:514\u2013517. doi: 10.1007\/BF02361253 .","journal-title":"J Gastroenterol"},{"key":"797_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.124.1.406","volume":"124","author":"S Abi-Nassif","year":"2003","unstructured":"Abi-Nassif S, Mark EJ, Fogel RB, Hallisey RK Jr. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS. Chest. 2003;124:406\u2013410. doi: 10.1378\/chest.124.1.406 .","journal-title":"Chest"},{"key":"797_CR15","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s10620-004-9602-3","volume":"49","author":"V Fuhrmann","year":"2004","unstructured":"Fuhrmann V, Kramer L, Bauer E, et\u00a0al. Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis\u00a0C infection. Dig Dis Sci. 2004;49:1966\u20131970. doi: 10.1007\/s10620-004-9602-3 .","journal-title":"Dig Dis Sci"},{"key":"797_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1665-2681(19)31895-2","volume":"7","author":"R Carrillo-Esper","year":"2008","unstructured":"Carrillo-Esper R, Gonz\u00e1lez-Avila D, Uribe-R\u00edos M, M\u00e9ndez-S\u00e1nchez N. Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis\u00a0C. Case report. Ann Hepatol. 2008;7:87\u201390.","journal-title":"Ann Hepatol"},{"key":"797_CR17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1572-0241.2006.00393_3.x","volume":"101","author":"AE Hillier","year":"2006","unstructured":"Hillier AE, Mand J, Raza A, Markov M, Nadir A. Consensus interferon induced interstitial pneumonitis in a patient with HCV. Am J Gastroenterol. 2006;101:200\u2013202. doi: 10.1111\/j.1572-0241.2005.50006_9.x .","journal-title":"Am J Gastroenterol"},{"key":"797_CR18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1572-0241.2005.50006_9.x","volume":"100","author":"C Renou","year":"2005","unstructured":"Renou C, Germain S, Harafa A, et\u00a0al. Pneumonia recurrence during chronic hepatitis\u00a0C treatment. Am J Gastroenterol. 2005;100:1625\u20131626. doi: 10.1111\/j.1572-0241.2005.50006_9.x .","journal-title":"Am J Gastroenterol"},{"key":"797_CR19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1055\/s-2002-33879","volume":"40","author":"KS Rothfuss","year":"2002","unstructured":"Rothfuss KS, Bode JC. Interstitial pneumonitis during combination therapy with interferon-\u03b1 and ribavirin in a patient with chronic hepatitis\u00a0C. Z Gastroenterol. 2002;40:807\u2013810. doi: 10.1055\/s-2002-33879 .","journal-title":"Z Gastroenterol"},{"key":"797_CR20","first-page":"92","volume":"30","author":"YC Chen","year":"2007","unstructured":"Chen YC, Lu SN, Lin MC. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis\u00a0C. Chang Gung Med J. 2007;30:92\u201397.","journal-title":"Chang Gung Med J"},{"key":"797_CR21","first-page":"103","volume":"13","author":"BK Son","year":"2007","unstructured":"Son BK, Sohn JH, Kim TY, Park YK, Jeon YC, Han DS. Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis\u00a0C. Korean J Hepatol. 2007;13:103\u2013107.","journal-title":"Korean J Hepatol"},{"key":"797_CR22","first-page":"405","volume":"26","author":"P Rocca","year":"2002","unstructured":"Rocca P, Dumortier J, Tani\u00e8re P, et\u00a0al. Induced interstitial pneumonitis: role of pegylated interferon alpha 2b. Gastroenterol Clin Biol. 2002;26:405\u2013408.","journal-title":"Gastroenterol Clin Biol"},{"key":"797_CR23","doi-asserted-by":"crossref","first-page":"242S","DOI":"10.1378\/chest.124.4_MeetingAbstracts.242S-a","volume":"124","author":"RR Nemivant","year":"2003","unstructured":"Nemivant RR, Hammadeh R, Shah N, Villanueva J. Interstitial pneumonitis due to pegylated interferon alfa-2b and ribavirin. Chest. 2003;124:242S. doi: 10.1378\/chest.124.1.242 .","journal-title":"Chest"},{"key":"797_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiology.195.3.7753988","volume":"195","author":"JS Park","year":"1995","unstructured":"Park JS, Lee KS, Kim JS, et\u00a0al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology. 1995;195:645\u2013648.","journal-title":"Radiology"},{"key":"797_CR25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","volume":"39","author":"DB Strader","year":"2004","unstructured":"Strader DB, Wright T, Thomas DL. Diagnosis, management, and treatment of hepatitis\u00a0C. Hepatology. 2004;39:1147\u20131171. doi: 10.1002\/hep.20119 .","journal-title":"Hepatology"},{"key":"797_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1021759120428","volume":"48","author":"V Tahan","year":"2003","unstructured":"Tahan V, Ozseker F, Guneylioglu D, et\u00a0al. Sarcoidosis after use of interferon for chronic hepatitis\u00a0C: report of a case and review of the literature. Dig Dis Sci. 2003;48:169\u2013173. doi: 10.1023\/A:1021759120428 .","journal-title":"Dig Dis Sci"},{"key":"797_CR27","unstructured":"Japanese Welfare Ministry. Report on drug side effect. No. 125, 1994."},{"key":"797_CR28","unstructured":"Abbas AK, Lichtman AH, Pober JS. Effector mechanisms of immune responses. In: Cellular and molecular immunology. 3rd ed. Philadelphia: WB Saunders; 1997:245\u2013338."},{"key":"797_CR29","first-page":"3","volume":"25","author":"EC Borden","year":"1998","unstructured":"Borden EC, Parkinson D. A perspective on the clinical effectiveness and tolerance of interferon alpha. Semin Oncol. 1998;25:3\u20138.","journal-title":"Semin Oncol"},{"key":"797_CR30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/gast.1997.v112.pm9041265","volume":"112","author":"H Tilg","year":"1997","unstructured":"Tilg H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology. 1997;112:1017\u20131021. doi: 10.1053\/gast.1997.v112.pm9041265 .","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-009-0797-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T19:50:32Z","timestamp":1589745032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-009-0797-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1007\/s10620-009-0797-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]}}}